β¨ Medicinal Product Notices and Tuberculosis Vaccinator Approvals
NEW ZEALAND GAZETTE, No. 159
30 NOVEMBER 2006
Product:
Ciprofloxacin
Active Ingredient:
Ciprofloxacin hydrochloride 873mg equivalent to ciprofloxacin 750mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product:
Enidin P
Active Ingredient:
Brimonidine tartrate 1.5mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan Sales LLC, Waco, Texas, United States of America
Product:
Maxiclear Hayfever & Sinus Relief
Active Ingredients:
Loratadine 2.5mg
Phenylephrine hydrochloride 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Matrix Laboratories Limited, Sinnar, Nashik, Maharashta, India
Product:
Maxiclear Sinus Relief
Active Ingredient:
Phenylephrine hydrochloride 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Matrix Laboratories Limited, Sinnar, Nashik, Maharashta, India
Product:
Nicotinell Classic
Active Ingredient:
Nicotine 2mg
Dosage Form:
Chewing gum
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty Limited
Manufacturer:
Fertin Pharma A/S, Vejle, Denmark
Product:
Nicotinell Classic
Active Ingredient:
Nicotine 4mg
Dosage Form:
Chewing gum
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty Limited
Manufacturer:
Fertin Pharma A/S, Vejle, Denmark
Product:
Procip
Active Ingredient:
Ciprofloxacin hydrochloride 291mg equivalent to ciprofloxacin 250mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product:
Procip
Active Ingredient:
Ciprofloxacin hydrochloride 582mg equivalent to ciprofloxacin 500mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Product:
Procip
Active Ingredient:
Ciprofloxacin hydrochloride 873mg equivalent to ciprofloxacin 750mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol Pharma (New Zealand) Pty Limited
Manufacturer:
IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Dated this 23rd day of November 2006.
BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8317
Tuberculosis Regulations 1951
Notice of Approval of Tuberculosis Vaccinators
Under the Tuberculosis Regulations 1951
Pursuant to Regulation 6 (4) of the Tuberculosis Regulations 1951, the Director-General of Health hereby gives notice that the following persons have been approved to perform vaccination against tuberculosis.
| Name | Address | Date of Approval |
|---|---|---|
| Susan Stewart | Napier | 30 June 2006 |
| Fiona Jackson | Havelock North | 30 June 2006 |
| Toni Searl | R.D. 1, Lyttelton | 12 June 2006 |
| Janet Steam | Tauranga | 21 July 2006 |
| Natalie Haenga-Parata | Gisborne | 16 August 2006 |
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 159
Gazette.govt.nz —
NZ Gazette 2006, No 159
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of Ciprofloxacin 500mg
(continued from previous page)
π₯ Health & Social Welfare23 November 2006
Medicines, Distribution, Consent, Ciprofloxacin, Bristol Pharma
- BARRY BORMAN, Acting Deputy Director-General, Public Health
π₯ Approval of Tuberculosis Vaccinators
π₯ Health & Social WelfareTuberculosis, Vaccination, Approval, Health Regulations
- Susan Stewart, Approved to perform tuberculosis vaccination
- Fiona Jackson, Approved to perform tuberculosis vaccination
- Toni Searl, Approved to perform tuberculosis vaccination
- Janet Steam, Approved to perform tuberculosis vaccination
- Natalie Haenga-Parata, Approved to perform tuberculosis vaccination
- Director-General of Health